"loratidine" meaning in English

{
  "head_templates": [
    {
      "args": {
        "1": "en",
        "2": "misspelling"
      },
      "expansion": "loratidine",
      "name": "head"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "alt_of": [
        {
          "word": "loratadine"
        }
      ],
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 June 9, Michael S. Broder et al., “Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria”, in American Journal of Clinical Dermatology, volume 16, →DOI",
          "text": "Table 3 Classes of medications filled a by patients with CIU/CSU CIU/CSU chronic idiopathic or spontaneous urticarial, NA not applicable a Claims data report only prescription fills, not actual medication use b The database did not include non-prescription antihistamines c Non-sedating H 1 -antihistamines included cetirizine HCl, desloratidine, fexofenadine HCl, levocetirizine dihydrochloride, and loratidine; sedating H 1 -antihistamines included brompheniramine, carbinoxamine, chlorpheniramine, clemastine, cyproheptadine, dexbrompheniramine, dexchlorpheniramine, diphenhydramine, doxylamine, pheniramine, promethazine, pyrilamine, tripelennamine, triprolidine d Cimetidine, ranitidine, famotidine, nizatidine e Montelukast, zafirlukast, zileuton f Parenteral medications do not report “days of supply” on claims, therefore the mean number of doses is reported here CIU/CSU patients had a mean of 15.1 all-cause office visits annually, 465 (7.3 %) were hospitalized at least once for any reason, and 1012 (15.9 %) had at least one ED visit (Table 4 ).",
          "type": "quotation"
        }
      ],
      "glosses": [
        "Misspelling of loratadine."
      ],
      "id": "en-loratidine-en-noun-SNmacXGR",
      "links": [
        [
          "loratadine",
          "loratadine#English"
        ]
      ],
      "tags": [
        "alt-of",
        "misspelling"
      ]
    }
  ],
  "word": "loratidine"
}

{
  "head_templates": [
    {
      "args": {
        "1": "en",
        "2": "misspelling"
      },
      "expansion": "loratidine",
      "name": "head"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "alt_of": [
        {
          "word": "loratadine"
        }
      ],
      "categories": [
        "English entries with incorrect language header",
        "English misspellings",
        "English non-lemma forms",
        "English terms with quotations"
      ],
      "examples": [
        {
          "ref": "2015 June 9, Michael S. Broder et al., “Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria”, in American Journal of Clinical Dermatology, volume 16, →DOI",
          "text": "Table 3 Classes of medications filled a by patients with CIU/CSU CIU/CSU chronic idiopathic or spontaneous urticarial, NA not applicable a Claims data report only prescription fills, not actual medication use b The database did not include non-prescription antihistamines c Non-sedating H 1 -antihistamines included cetirizine HCl, desloratidine, fexofenadine HCl, levocetirizine dihydrochloride, and loratidine; sedating H 1 -antihistamines included brompheniramine, carbinoxamine, chlorpheniramine, clemastine, cyproheptadine, dexbrompheniramine, dexchlorpheniramine, diphenhydramine, doxylamine, pheniramine, promethazine, pyrilamine, tripelennamine, triprolidine d Cimetidine, ranitidine, famotidine, nizatidine e Montelukast, zafirlukast, zileuton f Parenteral medications do not report “days of supply” on claims, therefore the mean number of doses is reported here CIU/CSU patients had a mean of 15.1 all-cause office visits annually, 465 (7.3 %) were hospitalized at least once for any reason, and 1012 (15.9 %) had at least one ED visit (Table 4 ).",
          "type": "quotation"
        }
      ],
      "glosses": [
        "Misspelling of loratadine."
      ],
      "links": [
        [
          "loratadine",
          "loratadine#English"
        ]
      ],
      "tags": [
        "alt-of",
        "misspelling"
      ]
    }
  ],
  "word": "loratidine"
}